Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Stocrin. Active Ingredient(s): Efavirenz 100 mg. Dosage Form: Capsule. NZ Sponsor: Merck Sharp & Dohme (New Zealand) Limited. Manufacturer(s): Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America. Product: Stocrin. Active Ingredient(s): Efavirenz 200 mg. Dosage Form: Capsule. NZ Sponsor: Merck Sharp & Dohme (New Zealand) Limited. Manufacturer(s): Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America. Product: Stocrin. Active Ingredient(s): Efavirenz 50 mg. Dosage Form: Capsule. NZ Sponsor: Merck Sharp & Dohme (New Zealand) Limited. Manufacturer(s): Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America. Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 4th day of November 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).